Skip to main content
logo
Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada flag Canada · Delayed Price · Currency is CAD
15.04
-0.25 (-1.64%)
Sep 24, 2026, 3:56 PM EST

Fennec Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
527361250400341145
Market Cap Growth
61.23%44.35%-37.55%17.23%135.62%-40.89%
Enterprise Value
469357238418334120
Last Close Price
15.0410.608.8715.1613.095.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.265.893.6514.25164.24-
PB Ratio
8.747.41-29.57-26.06-98.137.26
P/TBV Ratio
8.747.41---7.26
P/OCF Ratio
--6.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.595.833.4814.88160.94-
EV/EBITDA Ratio
--45.94---
EV/EBIT Ratio
--64.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---3.29-2.66-9.690.32
Debt / EBITDA Ratio
--5.37---
Net Debt / Equity Ratio
-0.97-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
40.395.95-2.03---
Asset Turnover
0.980.771.320.790.06-
Inventory Turnover
1.622.871.980.92--
Quick Ratio
5.215.715.712.925.4912.76
Current Ratio
5.856.376.383.565.8013.54
Return on Equity (ROE)
-18.58%-65.82%---359.22%-77.36%
Return on Assets (ROA)
-1.17%-6.80%4.47%-29.67%-57.21%-39.99%
Return on Capital Employed (ROCE)
-1.80%-10.50%6.80%-66.10%-101.20%-83.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.88%-3.70%-0.25%-5.30%-9.41%-15.16%
Buyback Yield / Dilution
-16.68%-4.70%-2.71%-1.14%-1.03%-9.71%